Management of upper aerodigestive tract bleeding on extracorporeal membrane oxygenation. by Hirose, MD, PhD, Hitoshi
Thomas Jefferson University
Jefferson Digital Commons
Department of Surgery Faculty Papers Department of Surgery
2-8-2013
Management of upper aerodigestive tract bleeding
on extracorporeal membrane oxygenation.
Hitoshi Hirose, MD, PhD
Thomas Jefferson University, Hitoshi.Hirose@Jefferson.edu
Let us know how access to this document benefits you
Follow this and additional works at: http://jdc.jefferson.edu/surgeryfp
Part of the Surgery Commons
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas
Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly
publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and
interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in
Department of Surgery Faculty Papers by an authorized administrator of the Jefferson Digital Commons. For more information, please contact:
JeffersonDigitalCommons@jefferson.edu.
Recommended Citation
Harrison MA, Baker AL, Roy S, Hirose H, Cavarocchi NC. Management of upper aerodigestive tract bleeding on extracorporeal
membrane oxygenation. Mechanical Circulatory Support 2013;4:20333.
Management of upper aerodigestive tract
bleeding on extracorporeal membrane
oxygenation
Meredith A. Harrison1, Adam L. Baker2, Sudeep Roy2,
Hitoshi Hirose1* and Nicholas C. Cavarocchi1
1Department of Surgery, Thomas Jefferson University, Philadelphia, PA, USA; 2Department
of Otolaryngology, Thomas Jefferson University, Philadelphia, PA, USA
Received: 24 December 2012; Revised: 11 January 2013; Accepted: 17 January 2013; Published: 8 February 2013
Abstract
Introduction: Bleeding complications are often encountered on extracorporeal membrane oxygenation
(ECMO). In a review of our own series, it was found that upper aero digestive tract bleeding was common and
that its management was often difficult. We propose an algorithm to help manage upper aerodigestive tract
bleeding in the anticoagulated, ECMO patient.
Methods: A retrospective chart review was performed of the patients who underwent veno-venous or veno-
arterial ECMO at our institution between July 2010 and July 2012. The patients that had upper aerodigestive
tract bleeding that required an otolaryngology consultation were identified. They were further investigated to
determine the location of bleed, and procedures were performed to control the bleeding.
Results: Among the 37 consecutive patients on ECMO, 11 (30%) had upper aerodigestive tract bleeding
events. Of these 11, 7 (63.6%) were secondary to an iatrogenic incident, such as placing a nasogastric tube or
transesophageal echo probe. All 11 patients were treated at bedside with conservative management and 3 were
treated in the operating room. Four patients (36%) treated with conservative management required repeated
procedures due to incomplete hemostasis, compared to no repeated procedure required once surgical
intervention in the operating room was complete.
Conclusion: Approximately one-third of the ECMO patients developed upper aerodigestive tract bleeding.
This bleeding should be controlled in a timely manner; otherwise it may result in massive transfusions.
Delaying intervention or conservative management may not be effective. We recommend surgical
intervention, if the initial conservative management failed and continued to bleed for more than 2436 hours.
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Introduction
B
leeding complications on extracorporeal mem-
brane oxygenation (ECMO) are often encoun-
tered and can be a difficult problem to handle
since ECMO patients need to remain on anticoagulation
to prevent the circuit from forming clots. One particular
complication, frequently encountered at many centers, is
upper aerodigestive tract bleeding, especially after ma-
nipulation or instrumentation. Presently there is not a
standardized algorithm for management of this bleeding,
which could affect the results for these patients, allowing
for continued anticoagulation, decreased number of
transfusions, and easier wean from ECMO. Here, we
present a case report to illustrate the review of our series
of upper aerodigestive bleeding in the ECMO patient and
attempt to develop a management algorithm to better
treat the bleeding, anticoagulated ECMO patient.
Case report
A 66-year-old female was placed on veno-arterial ECMO
(VA ECMO) for profound cardiogenic shock. On ECMO
day 6, a bedside transesophageal echocardiography
(TEE) probe was placed to evaluate heart function.
Oropharyngeal and nasopharyngeal bleeding were noted
immediately after the procedure. Packing of gauze into
the nares did not stop bleeding. Twenty-six hours later,
otolaryngology was consulted. The patient’s nares were
sprayed with oxymetolazone and were packed with
Merocel (Beaver-Visitec International, Inc. Waltham,
MA). The patient continued to bleed, her hemoglobin
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count continued to drop, and she required multiple
transfusions (Fig. 1). Otolaryngology (ear nose and
throat, ENT service) continued to attempt conservative
management, but the patient continued to bleed. At this
time, the patient’s partial thromboplastin time (PTT,
normal range 2535 seconds) was always in the range of
37 to 53 sec and there was no bleeding from any other
source. Because the patient’s oropharyngeal space was
still welling with blood even after oropharyngeal packing,
a decision was made to take the patient to the operating
room. By the time this decision was made, the patient
had received 32 units of packed red blood cells (PRBCs),
50 units of platelets, and 2 units of fresh frozen plasma.
The otolaryngology team had seen the patient over 10
separate times prior to surgical intervention. The patient
was unable to wean from ECMO because of uncertainty
of airway protection secondary to oropharyngeal bleed.
In the operating room, the patient was found to have a
laceration to her adenoid pad close to the midline, which
never would have been visualized at the bedside. The
bleeding vessel was cauterized using a Bovie. The patient
was successfully weaned from ECMO the following day
and required no further blood transfusions after this
point.
Methods
A retrospective chart review was performed for patients
who underwent veno-arterial (VA) or veno-venous (VV)
(veno-venous) ECMO in our institution from July 2010
to July 2011. Incidence of upper aerodigestive tract
bleeding that required an otolaryngology consultation
was recorded. All notes from the otolaryngology service
were reviewed to determine location of bleed, chronolo-
gical time line after instrumentation, and procedures
performed to stop the bleeding. This study was approved
by the local internal review board.
Results
Our institution had 37 consecutive patients on ECMO
from July 2010 to July 2012, of which 11 patients (30%)
had upper aerodigestive tract bleeding events (Table 1).
Among these 11 patients, 7 (63.6%) were secondary to
an iatrogenic incident, such as placing a nasogastric
tube, feeding tube, or transesophageal echo probe. Of
the 11 patients, Seven (64%) were from the nose or
nasopharynx, 4 were from the oropharynx (36%) and
none from the trachea. All of the upper aerodigestive
bleeding occurred within 12 hours of instrumentation and
otolaryngology consultation was obtained within 1218
hours. All patients were anticoagulated with intravenous
heparin at the time of the upper aerodigestive tract
bleeding, with an averaged PTT of 45 sec (range 2872).
Anticoagulation was initially held for 12 or 24 hours or
lowered (subsequent bleed) during the upper aerodiges-
tive tract bleeding. All patients underwent bedside ENT
procedures, including oxymetolazone spray in 11 (100%)
and Merocel packing in eight (73%). Repeated bleeding
after initial otolaryngology procedure was observed in
four patients (36%). Operative procedure was done in
three patients (27%) and none of them re-bled.
Discussion
We found that upper aerodigestive tract bleeding in
ECMO patients is not uncommon. Lowering or holding
anticoagulation did not solve the upper aerodigestive tract
bleeding according to our findings. Thus, an algorithm
should be made to follow when upper aerodigestive tract
bleeding complications occur. In consultation with our
otolaryngology department, management of these bleeds
was often complicated by persistent bleeding. In the case
presented, it is clear that conservative management was
not enough to control the bleeding. The lesion was not
visible until an operative intervention was performed.
It is often difficult to take ECMO patients to the
operating room because of the hemodynamic monitoring
and safety during the transportation. We developed an
algorithm to assist in this upper aerodigestive tract
bleeding management. If a patient develops upper aero-
digestive tract bleeding, anticoagulation profiles should
be reduced to 1.31.4 times the PTT, limited interventions
should be performed, suctioning should be done with
softer red rubber catheters rather than traditional naso-
tracheal suctioning devices, and conservative manage-
ment should be initiated, including oxymetolazone and
direct pressure via packing, and the otolaryngology
service should be consulted. If conservative management
fails to control the bleeding, nasopharyngolaryngoscopy
should be done to locate the site of the bleed. A different
procedure can be performed depending on the location of
the bleed as shown below, as interpreted by Gifford and
Orlandi (1) and Barnes, Spielmann and White (2).
Fig. 1. Cumulative transfusion of packed red cell given for
the presented case. Arrows demonstrate each otolaryngology
intervention. The last arrow indicates the definitive surgical
intervention in the operating room. PRBC: packed red blood
cell.
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Nares
According to our data, we found that most patients had
posterior nasopharyngeal sources for bleeding. Posterior
bleeding is often challenging to identify, but it can
be treated with packing. Bilateral bacitracin-coated
polycellulose packs, which are placed between the inferior
turbinate, septum, and posteriorly abutting the nasophar-
ynx, will tamponade anterior, posterior, and nasophar-
yngeal sources of epistaxis. Packs should be changed
within 72 hours to prevent the colonization of harmful
bacteria. The patient should be placed on an antibiotic
to cover streptococcus to prevent toxic shock syndrome.
If bleeding persists, or begins to present as an orophar-
yngeal bleed, further packing may be placed. If bleeding
continues to persist after 23 packs, further investigation
with nasal endoscopy may be warranted. Occasionally,
severe oropharyngeal hemorrhage may cause epistaxis,
although seldom without hemorrhage from the mouth.
Mouth
It is not unusual for posterior nasal cavity or nasophar-
yngeal bleeding to present from the mouth without
epistaxis. Thus, all oral bleeding must be approached by
ruling out nasopharyngeal bleeding. The nasal passage
is often used as a conduit for feeding, ventilation, and
esophageal probes. We found that an uninstrumented
spontaneous oropharyngeal bleed is less likely than an
instrumented nasopharyngeal bleed presenting as oral
hemorrhage. Thus, it is reasonable to pack a nose which
has recently been instrumented even if there is only
evidence of bleeding from the mouth. However, if bleeding
from the mouth persists, or if oropharyngeal bleeding is
highly suspicious, an oxymetolazone-saturated throat
pack may be placed. This can be typically achieved with
a paralyzed and sedated patient, using 12 Kling wraps
tied end-to-end, firmly packed in the direction toward the
hypopharynx. Again, packs should be changed within
72 hours, and appropriate prophylactic antibiotic therapy
should be initiated.
Endotracheal tube or trachea
Frequently, upper aerodigestive tract bleeding will pre-
sent alone with secretions from either the endotracheal
tube or in conjunction with nasal or oral hemorrhage.
If occurring alone and suspicion for hemoptysis is low,
evaluation with nasopharyngolaryngoscopy is warranted
to identify the source of bleeding. Occasionally, injury to
subsites within the hypopharynx, such as the piriform
sinus, can occur with nasogastric tubes, and may solely
present in this manner. Excessive hemorrhage from an
upper aerodigestive source may present as bloody leakage
around the cuff.
After thorough examination and conservative manage-
ment, if bleeding persists, surgical intervention should be
performed. The operating room allows for a controlled
environment in which a thorough exam and appropriate
interventions can be performed. Cauterization or ligation
of a bleeding vessel may be necessary. Taking the patient
to the operating room, sooner rather than later, can
decrease the amount of transfusion and upper aerodiges-
tive tract-specific bleeding-related morbidity, such as
aspiration pneumonia. Increased transfusion require-
ments, increased sedation requirements, and decreased
anticoagulation profiles can all be detrimental in the
ECMO patient.
Conclusions
In the ECMO patient, the incidence of upper aerodiges-
tive tract bleeding was as high as 30%. With such a high
incidence, it is important to have an algorithm to follow to
Table 1. Bleeding/transfusion data associated with ENT evaluations
Patients ENT evaluations/patient Days until bleeding stopped Transfusion totals
1 6 5 (once decannulated) 5 PRBCs; 2 FFP; 2 platelets
2 4 3 4 PRBCs; 1 platelets
3 12 Never stopped until LVAD placement 1 PRBC
4 6 7 1 PRBC; 2 platelets
5 2 1 None
6 1 1 None
7 1st consultation: 12 13 8 PRBCs; 8 platelets
2nd consultation: 2 2 3 cryoprecipitate
8 1 Expired None
9 6 6 2 PRBCs
10 1st consultation: 2 1 2 PRBCs
2nd consultation: 3 2
11 (presented) 10 9 32 PRBCs; 2 FFP; 50 platelets
FFP: fresh frozen plasma, LVAD: left ventricular assist device, PRBC: pure red blood cell.
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treat these patients in a timely fashion. Delaying inter-
vention with conservative management that is not suc-
cessful can prove detrimental. Conservative management
outlined in this article should be done by experienced
personnel as a first line approach. However, if bleeding
continues for more than 2436 hours and the patient
demonstrates continued blood transfusion requirements,
surgical intervention may be necessary. Every patient
should be approached on a case-by-case basis, but
delaying repair of a laceration or cauterization of a
bleeding vessel can increase morbidity in this patient
population. Taking a patient to the operating room for a
thorough evaluation and treatment should not be delayed.
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